Sandostatin Impairs Postresection Intestinal Adaptation in a Rat Model of Short Bowel Syndrome


Because of its antisecretory properties, sandostatin has been advocated for the treatment of patients with short bowel syndrome (SBS). This study was conducted to determine the effect of sandostatin on structural intestinal adaptation, cell proliferation and apoptosis in a rat model of SBS. Sprague-Dawley rats were divided into three experimental groups… (More)
DOI: 10.1023/A:1019641416671